These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 26660171

  • 21. Simultaneous determination of four antiepileptic drugs in human plasma samples using an ultra-high-performance liquid chromatography tandem mass spectrometry method and its application in therapeutic drug monitoring.
    Dupouey J, Doudka N, Belo S, Blin O, Guilhaumou R.
    Biomed Chromatogr; 2016 Dec; 30(12):2053-2060. PubMed ID: 27417975
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A simple method to monitor plasma concentrations of oxcarbazepine, carbamazepine, their main metabolites and lamotrigine in epileptic patients.
    Franceschi L, Furlanut M.
    Pharmacol Res; 2005 Apr; 51(4):297-302. PubMed ID: 15683742
    [Abstract] [Full Text] [Related]

  • 24. Developmental and therapeutic pharmacology of antiepileptic drugs.
    Miura H.
    Epilepsia; 2000 Apr; 41 Suppl 9():2-6. PubMed ID: 11156504
    [Abstract] [Full Text] [Related]

  • 25. Development and validation of a LC/MS/MS method for simultaneous quantification of oxcarbazepine and its main metabolites in human serum.
    Paglia G, D'Apolito O, Garofalo D, Scarano C, Corso G.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec 15; 860(2):153-9. PubMed ID: 17996501
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Simultaneous quantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrometry detection.
    Juenke JM, Brown PI, Johnson-Davis KL, McMillin GA.
    Ther Drug Monit; 2011 Apr 15; 33(2):209-13. PubMed ID: 21297550
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA, American Academy of Neurology Therapeutics and Technology Assessment Subcommittee, American Academy of Neurology Quality Standards Subcommittee, American Epilepsy Society Therapeutics and Technology Assessment Subcommittee, American Epilepsy Society Quality Standards Subcommittee.
    Epilepsia; 2004 May 15; 45(5):410-23. PubMed ID: 15101822
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Analytical and clinical validation of an LC-MS/MS method for carbamazepine, lamotrigine and levetiracetam in dried blood spots.
    Besten-Bertholee DD, Wegner I, Touw DJ, Ter Horst PGJ.
    Eur J Hosp Pharm; 2024 Aug 22; 31(5):450-454. PubMed ID: 36894298
    [Abstract] [Full Text] [Related]

  • 31. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
    Wang XQ, Lang SY, Shi XB, Tian HJ, Wang RF, Yang F.
    Seizure; 2010 Nov 22; 19(9):562-6. PubMed ID: 20888266
    [Abstract] [Full Text] [Related]

  • 32. [Clinical application of newer anti-epileptic drugs].
    Terada K, Inoue Y.
    Rinsho Shinkeigaku; 2012 Nov 22; 52(11):1088-90. PubMed ID: 23196525
    [Abstract] [Full Text] [Related]

  • 33. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C, De Smedt H, Stockis A.
    Epilepsia; 2007 Nov 22; 48(11):2111-5. PubMed ID: 17651416
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA, American Academy of Neurology Therapeutics and Technology Assessment Subcommittee, American Academy of Neurology Quality Standards Subcommittee, American Epilepsy Society Quality Standards Subcommittee, American Epilepsy Society Therapeutics and Technology Assessment Subcommittee.
    Epilepsia; 2004 May 22; 45(5):401-9. PubMed ID: 15101821
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Determination of a selection of anti-epileptic drugs and two active metabolites in whole blood by reversed phase UPLC-MS/MS and some examples of application of the method in forensic toxicology cases.
    Karinen R, Vindenes V, Hasvold I, Olsen KM, Christophersen AS, Øiestad E.
    Drug Test Anal; 2015 Jul 22; 7(7):634-44. PubMed ID: 25331692
    [Abstract] [Full Text] [Related]

  • 39. Development of a UPLC-MS/MS Method to Simultaneously Measure 13 Antiepileptic Drugs with Deuterated Internal Standards.
    Cha JH, Choi H, Yim J, Kim KJ, Nam M, Nam MH, Lee CK, Kim DW, Cho Y, Yun SG.
    Clin Lab; 2024 Sep 01; 70(9):. PubMed ID: 39257113
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.